{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:22:02Z","timestamp":1789611722270,"version":"build-2803163510"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T00:00:00Z","timestamp":1531872000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s40620-018-0514-2","type":"journal-article","created":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T22:57:42Z","timestamp":1531954662000},"page":"83-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The association of endothelin-1 levels with renal survival in polycystic kidney disease patients"],"prefix":"10.1093","volume":"32","author":[{"given":"Ismail","family":"Kocyigit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2571-7385","authenticated-orcid":false,"given":"Eray","family":"Eroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Safa","family":"Kaynar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Kocer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seval","family":"Kargi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokmen","family":"Zararsiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruslan","family":"Bayramov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Imamoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat Hayri","family":"Sipahioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Tokgoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munis","family":"Dundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oktay","family":"Oymak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,18]]},"reference":[{"issue":"9569","key":"514_CR1","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","volume":"369","author":"VE Torres","year":"2007","unstructured":"Torres VE, Harris PC, Pirson Y (2007) Autosomal dominant polycystic kidney disease. Lancet 369(9569):1287\u20131301","journal-title":"Lancet"},{"key":"514_CR2","doi-asserted-by":"crossref","first-page":"1 94","DOI":"10.1681\/ASN.V121194","volume":"12","author":"T Ecder","year":"2001","unstructured":"Ecder T, Schrier RW (2001) Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects. J Am Soc Nephrol 12:1 94\u2013200","journal-title":"J Am Soc Nephrol"},{"key":"514_CR3","doi-asserted-by":"publisher","first-page":"3 32","DOI":"10.1056\/NEJM199307293290508","volume":"329","author":"PA Gabow","year":"1993","unstructured":"Gabow PA (1993) Autosomal dominant polycystic kidney disease. N Engl J Med 329:3 32\u2013342","journal-title":"N Engl J Med"},{"key":"514_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/ki.2009.128","volume":"76","author":"VE Torres","year":"2009","unstructured":"Torres VE, Harris PC (2009) Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 76:149\u2013168","journal-title":"Kidney Int"},{"key":"514_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000328701","volume":"172","author":"M-Y Chang","year":"2011","unstructured":"Chang M-Y, Ong ACM (2011) Endothelin in renal physiology and disease. Contrib Nephrol 172:200\u2013209","journal-title":"Contrib Nephrol"},{"issue":"6163","key":"514_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/332411a0","volume":"332","author":"M Yanagisawa","year":"1988","unstructured":"Yanagisawa M, Kurihara H, Kimura S et al (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332(6163):411\u2013415","journal-title":"Nature"},{"issue":"2","key":"514_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/MNH.0b013e328335f91f","volume":"19","author":"DE Kohan","year":"2010","unstructured":"Kohan DE (2010) Endothelin, hypertension and chronic kidney disease: new insights. Curr Opin Nephrol Hypertens 19(2):134\u2013139","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"514_CR8","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1172\/JCI119297","volume":"99","author":"B Hocher","year":"1997","unstructured":"Hocher B, Thdne-Reineke C, Rohmeiss P et al (1997) Endothelin-l transgenic mice develop renal cysts, interstitial fibrosis and glomerulosclerosis but not hypertension. J Clin Invest 99:1380\u20131389","journal-title":"J Clin Invest"},{"issue":"7\u20138","key":"514_CR9","first-page":"1140","volume":"2","author":"X Lai","year":"2008","unstructured":"Lai X, Bacallao RL, Blazer-Yost BL, Hong D, Mason SB, Witzmann FA (2008) Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients. Proteomics 2(7\u20138), 1140\u20131152","journal-title":"Proteomics"},{"key":"514_CR10","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1159\/000068518","volume":"93","author":"AC Ong","year":"2003","unstructured":"Ong AC, Newby LJ, Dashwood MR (2003) Expression and cellular localisation of renal endothelin-1 and endothelin receptor subtypes in autosomal-dominant polycystic kidney disease. Nephron Exp Nephrol 93:e80","journal-title":"Nephron Exp Nephrol"},{"key":"514_CR11","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1681\/ASN.V441064","volume":"4","author":"T Nakamura","year":"1993","unstructured":"Nakamura T, Ebihara I, Fukui M et al (1993) Increased endothelin and endothelin receptor mRNA expression in polycystic kidneys of cpk mice. J Am Soc Nephrol 4:1064\u20131072","journal-title":"J Am Soc Nephrol"},{"key":"514_CR12","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1681\/ASN.V971169","volume":"9","author":"B Hocher","year":"1998","unstructured":"Hocher B, Zart R, Schwarz A et al (1998) Renal endothelin system in polycystic kidney disease. J Am Soc Nephrol 9:1169\u20131177","journal-title":"J Am Soc Nephrol"},{"key":"514_CR13","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/348732a0","volume":"348","author":"T Sakurai","year":"1990","unstructured":"Sakurai T, Yanagisawa M, Takuwa Y et al (1990) Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732\u2013735","journal-title":"Nature"},{"key":"514_CR14","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/348730a0","volume":"348","author":"H Arai","year":"1990","unstructured":"Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730\u2013732","journal-title":"Nature"},{"issue":"2","key":"514_CR15","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1681\/ASN.2006090994","volume":"18","author":"MY Chang","year":"2007","unstructured":"Chang MY, Parker E, El Nahas M, Haylor JL, Ong AC (2007) Endothelin B receptor blockade accelerates disease progression in a murine model of autosomal dominant polycystic kidney disease. J Am Soc Nephrol 18(2):560\u2013569","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"514_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","volume":"63","author":"LA Inker","year":"2014","unstructured":"Inker LA, Astor BC, Fox CH et al (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63(5):713\u2013735","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"514_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612","journal-title":"Ann Intern Med"},{"issue":"6","key":"514_CR18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499\u2013502","journal-title":"Clin Chem"},{"issue":"8828","key":"514_CR19","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/0140-6736(92)93147-F","volume":"340","author":"DS Celermajer","year":"1992","unstructured":"Celermajer DS, Sorensen KE, Gooch VM et al (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340(8828):1111\u20131115","journal-title":"Lancet"},{"issue":"2","key":"514_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","volume":"39","author":"MC Corretti","year":"2002","unstructured":"Corretti MC, Anderson TJ, Benjamin EJ, International Brachial Artery Reactivity Task Force et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39(2):257\u2013265","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"514_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000355375","volume":"38","author":"KT Bae","year":"2013","unstructured":"Bae KT, Tao C, Wang J, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) et al (2013) Novel approach to estimate kidney and cyst volumes using mid-slice magnetic resonance images in polycystic kidney disease. Am J Nephrol 38(4):333\u2013341","journal-title":"Am J Nephrol"},{"issue":"5","key":"514_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013423","journal-title":"Genet Med"},{"key":"514_CR23","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1111\/j.1523-1755.2005.00201.x","volume":"67","author":"ACM Ong","year":"2005","unstructured":"Ong ACM, Harris PC (2005) Molecular pathogenesis of ADPKD: the polycystin complex gets complex. Kidney Int 67:1234\u20131247","journal-title":"Kidney Int"},{"issue":"11","key":"514_CR24","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1681\/ASN.2013111184","volume":"25","author":"RW Schrier","year":"2014","unstructured":"Schrier RW, Brosnahan G, Cadnapaphornchai MA et al (2014) Predictors of autosomal dominant polycystic kidney disease progression. J Am Soc Nephrol 25(11):2399\u20132418","journal-title":"J Am Soc Nephrol"},{"key":"514_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-018-0470-x","author":"BR Di Iorio","year":"2018","unstructured":"Di Iorio BR, Cupisti A, D\u2019Alessandro C, Bellasi A, Barbera V, Di Lullo L (2018) Nutritional therapy in autosomal dominant polycystic kidney disease. J Nephrol. https:\/\/doi.org\/10.1007\/s40620-018-0470-x (Epub ahead of print)","journal-title":"J Nephrol"},{"issue":"1","key":"514_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40620-017-0396-8","volume":"31","author":"L Girardat-Rotar","year":"2018","unstructured":"Girardat-Rotar L, Puhan MA, Braun J, Serra AL (2018) Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study. J Nephrol 31(1):87\u201394","journal-title":"J Nephrol"},{"issue":"3","key":"514_CR27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000354317","volume":"38","author":"I Kocyigit","year":"2013","unstructured":"Kocyigit I, Yilmaz MI, Unal A et al (2013) A link between the intrarenal renin angiotensinsystem and hypertension in autosomal dominant polycystic kidney disease. Am J Nephrol 38(3):218\u2013225","journal-title":"Am J Nephrol"},{"issue":"2","key":"514_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40620-014-0045-4","volume":"27","author":"I Kocyigit","year":"2014","unstructured":"Kocyigit I, Eroglu E, Orscelik O et al (2014) Pentraxin 3 as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease. J Nephrol 27(2):181\u2013186","journal-title":"J Nephrol"},{"issue":"1","key":"514_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000339440","volume":"36","author":"I Kocyigit","year":"2012","unstructured":"Kocyigit I, Kaya MG, Orscelik O et al (2012) Early arterial stiffness and inflammatory bio-markers in normotensive polycystic kidney disease patients. Am J Nephrol 36(1):11\u201318","journal-title":"Am J Nephrol"},{"issue":"3\u20134","key":"514_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000369105","volume":"4","author":"I Kocyigit","year":"2014","unstructured":"Kocyigit I, Taheri S, Sener EF et al (2014) Endothelial nitric oxide synthase gene expression is associated with hypertension in autosomal dominant polycystic kidney disease. Cardiorenal Med 4(3\u20134):269\u2013279","journal-title":"Cardiorenal Med"},{"key":"514_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0272-6386(12)80212-5","volume":"24","author":"C Munemura","year":"1994","unstructured":"Munemura C, Uemasu J, Kawasaki H (1994) Epidermal growth factor and endothelin in cyst fluid from autosomal dominant polycystic kidney disease cases: possible evidence of heterogeneity in cystogenesis. Am J Kidney Dis 24:561\u2013568","journal-title":"Am J Kidney Dis"},{"key":"514_CR32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000424407","volume":"115","author":"R Giusti","year":"1995","unstructured":"Giusti R, Neri M, Angelini D et al (1995) Plasma concentration of endothelin and arterial pressure in patients with ADPKD. Contrib Nephrol 115:118\u2013121","journal-title":"Contrib Nephrol"},{"key":"514_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000328701","volume":"172","author":"MY Chang","year":"2011","unstructured":"Chang MY, Ong AC (2011) Endothelin in polycystic kidney disease. Contrib Nephrol 172:200\u2013209","journal-title":"Contrib Nephrol"},{"key":"514_CR34","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1681\/ASN.2008080882","volume":"20","author":"RW Schrier","year":"2009","unstructured":"Schrier RW (2009) Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 20:1888\u20131893","journal-title":"J Am Soc Nephrol"},{"key":"514_CR35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/01.ASN.0000042165.63601.65","volume":"14","author":"B Hocher","year":"2003","unstructured":"Hocher B, Kalk P, Slowinski T et al (2003) ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease. J Am Soc Nephrol 14:367\u2013376","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"514_CR36","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nrneph.2011.109","volume":"7","author":"JJ Grantham","year":"2011","unstructured":"Grantham JJ, Mulamalla S, Swenson-Fields KI (2011) Why kidneys fail in autosomal dominant polycystic kidney disease. Nat Rev Nephrol 7(10):556\u2013566","journal-title":"Nat Rev Nephrol"},{"key":"514_CR37","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/bcp.12136","volume":"76","author":"M-Y Chang","year":"2013","unstructured":"Chang M-Y, Ong ACM (2013) New treatments for autosomal dominant polycystic kidney disease. Br J Clin Pharm 76:524\u2013535","journal-title":"Br J Clin Pharm"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-018-0514-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0514-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-018-0514-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:09Z","timestamp":1777564569000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/32\/1\/83\/8328163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,18]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["514"],"URL":"https:\/\/doi.org\/10.1007\/s40620-018-0514-2","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,18]]},"assertion":[{"value":"4 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}